PDF(Pubmed)
Abstract：
The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.
摘要：
诊断,治疗,正电子发射断层扫描/计算机断层扫描（PET/CT）和MRI均使妇科恶性肿瘤的治疗受益。PET/CT提供了有关疾病局部范围以及弥漫性转移受累的重要信息。MRI提供软组织描绘和局部区域疾病受累。这两种技术的结合是诊断的关键，治疗计划,并评估妇科恶性肿瘤的治疗反应。这篇综述旨在评估PET/MRI在妇科癌症患者中的表现，并概述了PET/MR系统在专门应用于妇科恶性肿瘤时的技术挑战和临床优势。
